These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18434388)

  • 1. Regression of glomerulosclerosis in subtotally nephrectomized rats: effects of monotherapy with losartan, spironolactone, and their combination.
    Piecha G; Koleganova N; Gross ML; Geldyyev A; Adamczak M; Ritz E
    Am J Physiol Renal Physiol; 2008 Jul; 295(1):F137-44. PubMed ID: 18434388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
    Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased renoprotection with ACE inhibitor plus aldosterone antagonist as compared to monotherapies--the effect on podocytes.
    Nemeth Z; Kokeny G; Godo M; Mózes M; Rosivall L; Gross ML; Ritz E; Hamar P
    Nephrol Dial Transplant; 2009 Dec; 24(12):3640-51. PubMed ID: 19666910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of existing glomerulosclerosis by inhibition of aldosterone.
    Aldigier JC; Kanjanbuch T; Ma LJ; Brown NJ; Fogo AB
    J Am Soc Nephrol; 2005 Nov; 16(11):3306-14. PubMed ID: 16192423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of spironolactone and losartan regarding long-term blood pressure and target organ damage.
    Baumann M; Hermans JJ; Janssen BJ; Peutz-Kootstra C; Witzke O; Heemann U; Smits JF; Boudier HA
    J Hypertens; 2007 Dec; 25(12):2504-11. PubMed ID: 17984673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats.
    Adamczak M; Gross ML; Krtil J; Koch A; Tyralla K; Amann K; Ritz E
    J Am Soc Nephrol; 2003 Nov; 14(11):2833-42. PubMed ID: 14569093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature.
    Adamczak M; Gross ML; Amann K; Ritz E
    J Am Soc Nephrol; 2004 Dec; 15(12):3063-72. PubMed ID: 15579509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy.
    Álvarez-Prats A; Hernández-Perera O; Díaz-Herrera P; Ucero ÁC; Anabitarte-Prieto A; Losada-Cabrera A; Ortiz A; Rodríguez-Pérez JC
    Nephrol Dial Transplant; 2012 Jul; 27(7):2720-33. PubMed ID: 22302208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ramipril, nifedipine, and moxonidine on glomerular morphology and podocyte structure in experimental renal failure.
    Amann K; Nichols C; Tornig J; Schwarz U; Zeier M; Mall G; Ritz E
    Nephrol Dial Transplant; 1996 Jun; 11(6):1003-11. PubMed ID: 8671960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat.
    Kuhlmann A; Haas CS; Gross ML; Reulbach U; Holzinger M; Schwarz U; Ritz E; Amann K
    Am J Physiol Renal Physiol; 2004 Mar; 286(3):F526-33. PubMed ID: 14600034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of combined endothelin and angiotensin II antagonism on growth factor-induced proliferation of vascular smooth muscle cells isolated from uremic rats.
    Wolf SC; Sauter G; Risler T; Brehm BR
    Ren Fail; 2005; 27(4):465-74. PubMed ID: 16060137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of specific and non-specific endothelin receptor antagonists on renal morphology in rats with surgical renal ablation.
    Nabokov A; Amann K; Wagner J; Gehlen F; Münter K; Ritz E
    Nephrol Dial Transplant; 1996 Mar; 11(3):514-20. PubMed ID: 8671823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal protective effects of specific cyclooxygenase-2 inhibitor in rats with subtotal renal ablation].
    Kong WX; Ma J; Gu Y; Yang HC; Zuo YQ; Lin SY
    Zhonghua Nei Ke Za Zhi; 2003 Mar; 42(3):186-90. PubMed ID: 12816702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of blocking renin-angiotensin system on the progression of renal injury in glomerulosclerosis.
    Ji Z; Huang C; Liang C; Chen B; Chen S; Sun W
    Cell Mol Immunol; 2005 Apr; 2(2):150-4. PubMed ID: 16191423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerulosclerosis and progression: effect of subantihypertensive doses of alpha and beta blockers.
    Amann K; Koch A; Hofstetter J; Gross ML; Haas C; Orth SR; Ehmke H; Rump LC; Ritz E
    Kidney Int; 2001 Oct; 60(4):1309-23. PubMed ID: 11576345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients.
    Renke M; Tylicki L; Rutkowski P; Wojnarowski K; Lysiak-Szydlowska W; Rutkowski B
    Scand J Urol Nephrol; 2005; 39(6):511-7. PubMed ID: 16303729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure-independent additive effects of pharmacologic blockade of the renin-angiotensin and endothelin systems on progression in a low-renin model of renal damage.
    Amann K; Simonaviciene A; Medwedewa T; Koch A; Orth S; Gross ML; Haas C; Kuhlmann A; Linz W; Schölkens B; Ritz E
    J Am Soc Nephrol; 2001 Dec; 12(12):2572-2584. PubMed ID: 11729225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent effects on blood pressure and renal function of perindopril alone or combined with losartan in Lyon hypertensive rats.
    Naelten G; Liu KL; Chapuis B; Lo M
    Am J Hypertens; 2005 May; 18(5 Pt 1):699-706. PubMed ID: 15882554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A
    Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.